BC
NEO icon

Barrett & Company’s NeoGenomics NEO Stock Holding History

Barrett & Company’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$3.14K – 615
2024
Q1 		$3.14K Hold
200
– – ﹤0.01% 522
2023
Q4 		$3.24K Hold
200
– – ﹤0.01% 508
2023
Q3 		$2.46K Hold
200
– – ﹤0.01% 530
2023
Q2 		$3.21K Hold
200
– – ﹤0.01% 500
2023
Q1 		$3.48K Hold
200
– – ﹤0.01% 471
2022
Q4 		$1.85K Hold
200
– – ﹤0.01% 522
2022
Q3 		$1.85K Buy
+200
New +$1.99K ﹤0.01% 522

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Barrett & Company's NEO Position: Q2 2024 in Review

Barrett & Company sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 200 shares — an estimated $3.14K sold.

Barrett & Company first reported a position in NEO in Q3 2022 and held it in 7 quarters. The position peaked at $3.48K in Q1 2023. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Barrett & Company reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Barrett & Company sold 200 NeoGenomics shares in Q2 2024, an estimated $3.14K.
  • Barrett & Company first reported a position in NeoGenomics in Q3 2022 and held it in 7 quarters.
  • Barrett & Company's NeoGenomics position peaked at $3.48K in Q1 2023.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Barrett & Company's 13F filing for Q2 2024, filed 25 Jul 2024.